The search for value is getting harder, but its not impossible, not yet. I wonder if at the point of impossibility to find decent value, the end of the bubble will appear. Either way, I don't care. I'm not in the business of market timing, I'm in the business of finding value and extracting profits … Continue reading Another Way To Play Pharmaceuticals (SWKH)
Category: Net Net Stocks
Timmins Gold Deep Value Buyout
Below is a snapshot of my write-up on Timmins Gold (TGD) from April 28th. TGD popped up on my deep value screener and was hanging around the top of the list for a while but I cared not to look. However, after looking at the price action of gold, and developing a personal hypothesis on … Continue reading Timmins Gold Deep Value Buyout
InsipreMD (NSPR) A Medical Cigar Butt
Quick Fundamental Figures Price to Book - 0.23 Price to Sales - 0.19 EV - to - EBITDA - 0.06 Price to Net Cash - 0.43 Price to NCAV - 0.28 A Cigar Butt With A Few Puffs InspireMD Inc is a medical device company. The Company is engaged in the development and commercialization of … Continue reading InsipreMD (NSPR) A Medical Cigar Butt
Juniper Pharmaceuticals Distress Play
Pharmaceutical companies. When I think of biopharma, the first word that pops into my head is, "stressful". I'm right, to an extent. Pharmaceutical companies, especially those in the small cap / micro cap space live and die by drug approvals and pipeline passes. Failure to pass a drug test or failure to bring a product … Continue reading Juniper Pharmaceuticals Distress Play
The Market Plunger 